After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Black Diamond Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Black Diamond Therapeutics Inc is $125.10M. A total of 0.95 million shares were traded on the day, compared to an average of 3.43M shares.
In the most recent transaction, BIOTECH GROWTH N V sold 5,784,292 shares of BDTX for 2.07 per share on Mar 19 ’25. After the transaction, the 10% Owner now owns 2,733,547 company shares. In a previous transaction on Aug 28 ’24, Versant Venture Capital VI, L. sold 221,600 shares at 6.32 per share. BDTX shares that 10% Owner owns now total 3,726,341.
Among the insiders who bought shares, David Epstein acquired of 50,000 shares on Jul 31 ’24 at a per-share price of $6.20. In another insider transaction, David Epstein bought 50,000 shares at $6.20 per share on Jul 26 ’24.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, BDTX has a high of $6.75 and a low of $1.20.
As of this writing, BDTX has an earnings estimate of -$0.22 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.21 per share and a lower estimate of -$0.24.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. BDTX’s latest balance sheet shows that the firm has $209.79M in Cash & Short Term Investments as of fiscal 2021. There were $28.46M in debt and $23.64M in liabilities at the time. Its Book Value Per Share was $2.50, while its Total Shareholder’s Equity was $195.90M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BDTX is Buy with a score of 5.00.
